Pennant Investors »

Allovir shares owned by Pennant Investors

Quarter-by-quarter ownership of Allovir (ALVR) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Allovir

Tip: Access up to 7 years of quarterly data

All positions including Allovir held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allovir by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $163k 216k 0.75

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Allovir

EcoR1 Capital
Artal Group
Octagon Capital Advisors
BlackRock
Millennium Management
Vanguard Group
Irenic Capital Management
Redmile Group
Acadian Asset Management
Geode Capital Management
State Street Corporation
American International
Acuitas Investments
D. E. Shaw & Co
Renaissance Technologies

View all funds holding Allovir